Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 9 (1), 528

Schistosomiasis Vaccines: Where Do We Stand?


Schistosomiasis Vaccines: Where Do We Stand?

Biniam Mathewos Tebeje et al. Parasit Vectors.


Schistosomiasis, caused mainly by S. mansoni, S. haematobium and S. japonicum, continues to be a serious tropical disease and public health problem resulting in an unacceptably high level of morbidity in countries where it is endemic. Praziquantel, the only drug currently available for treatment, is unable to kill developing schistosomes, it does not prevent re-infection and its continued extensive use may result in the future emergence of drug-resistant parasites. This scenario provides impetus for the development and deployment of anti-schistosome vaccines to be used as part of an integrated approach for the prevention, control and eventual elimination of schistosomiasis. This review considers the present status of candidate vaccines for schistosomiasis, and provides some insight on future vaccine discovery and design.

Keywords: Antigen discovery; Immune protection; Immune response; Schistosoma haematobium; Schistosoma japonicum; Schistosoma mansoni; Schistosomiasis; Vaccine.

Similar articles

  • Development of a Schistosomiasis Vaccine
    AJ Molehin et al. Expert Rev Vaccines 15 (5), 619-27. PMID 26651503. - Review
    Schistosomiasis is a neglected tropical disease (NTD) of public health importance. Despite decades of implementation of mass praziquantel therapy programs and other contr …
  • Still Hope for Schistosomiasis Vaccine
    A Ricciardi et al. Hum Vaccin Immunother 11 (10), 2504-8. PMID 26176659.
    Schistosomiasis is a parasitic disease caused by helminths belonging to the Schistosoma genus. Approximately 700 million people are at risk of infection and 200 million p …
  • Current Status of Vaccines for Schistosomiasis
    DP McManus et al. Clin Microbiol Rev 21 (1), 225-42. PMID 18202444. - Review
    Schistosomiasis, caused by trematode blood flukes of the genus Schistosoma, is recognized as the most important human helminth infection in terms of morbidity and mortali …
  • Prospects for a Schistosome Vaccine
    A Capron et al. Curr Drug Targets Immune Endocr Metabol Disord 2 (3), 281-90. PMID 12476492. - Review
    After some 20 years experience it is generally agreed that chemotherapy against schistosomiasis, a parasitic disease which should be considered a consequence of a chronic …
  • Schistosomiasis in Egypt: A Never-Ending Story?
    AA Othman et al. Acta Trop 148, 179-90. PMID 25959770. - Review
    Schistosomiasis has plagued the Egyptian population since the antiquity. The disease is still a public health problem in Egypt, despite the tendency of being overlooked. …
See all similar articles

Cited by 30 PubMed Central articles

See all "Cited by" articles


    1. Sarvel AK, Oliveira AA, Silva AR, Lima AC, Katz N. Evaluation of a 25-year-program for the control of schistosomiasis mansoni in an endemic area in Brazil. PLoS Negl Trop Dis. 2011;5(3):e990. doi: 10.1371/journal.pntd.0000990. - DOI - PMC - PubMed
    1. World Health Organization. Schistosomiasis. In: Schistosomiasis Fact Sheet No 115. World Health Organization. 2015. Accessed Aug 2015.
    1. Nour NM. Schistosomiasis: health effects on women. Rev Obst Gynecol. 2010;3(1):28. - PMC - PubMed
    1. Christinet V, Lazdins-Helds JK, Stothard JR, Reinhard-Rupp J. Female genital schistosomiasis (FGS): from case reports to a call for concerted action against this neglected gynaecological disease. Int J Parasitol. 2016;46(7):395–404. doi: 10.1016/j.ijpara.2016.02.006. - DOI - PubMed
    1. Cioli D, Pica-Mattoccia L, Basso A, Guidi A. Schistosomiasis control: praziquantel forever? Mol Biochem Parasitol. 2014;195(1):23–9. doi: 10.1016/j.molbiopara.2014.06.002. - DOI - PubMed

Publication types

MeSH terms